Ocular Therapeutix Inc
OCUL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.37B
Close$
$-1.16
118.7% downside
Current Fair Value
118.7% downsideOvervalued by 118.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $915.74 Million |
| Earnings per Share | $-1.42 |
| Beta | 0.99 |
| Outstanding Shares | 225,515,234 |
Return
| Return on Equity | -74.12% |
|---|---|
| Return on Assets | -53.96% |
| Return on Invested Capital | -61.24% |
Valuation & Multiples
| P/E Ratio | -4.25 |
|---|---|
| PEG | -11.64 |
| Price to Sales | - |
| Price to Book Ratio | 6.21 |
| Enterprise Value to Revenue | 18.18 |
| Enterprise Value to EBIT | -2.76 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
-$0.42
Est. -$0.36Revenue
$12.87 M
Est. $14.27 MNext Earnings Call
Expected Date
February 4, 2027
EPS Estimate
-$0.45
Consensus analyst estimateRevenue Estimate
$13.76 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 29.43% |
|---|---|
| Total Calls | 10,000▼ 99.50% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.65%▼ 80.49% |
|---|---|
| Total Invested | $218.22M▼ 89.35% |
| Investors Holding | 87▼ 190.00% |
About Ocular Therapeutix Inc
CEO: Antony Mattessich
